Logo image of CBLL

CERIBELL INC (CBLL) Stock Fundamental Analysis

NASDAQ:CBLL - Nasdaq - US15678C1027 - Currency: USD

22.69  +0.47 (+2.12%)

After market: 22.69 0 (0%)

Fundamental Rating

3

Overall CBLL gets a fundamental rating of 3 out of 10. We evaluated CBLL against 190 industry peers in the Health Care Equipment & Supplies industry. The financial health of CBLL is average, but there are quite some concerns on its profitability. While showing a medium growth rate, CBLL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CBLL had negative earnings in the past year.
In the past year CBLL has reported a negative cash flow from operations.
CBLL Yearly Net Income VS EBIT VS OCF VS FCFCBLL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of CBLL (-17.95%) is comparable to the rest of the industry.
CBLL has a Return On Equity of -21.16%. This is in the better half of the industry: CBLL outperforms 60.85% of its industry peers.
Industry RankSector Rank
ROA -17.95%
ROE -21.16%
ROIC N/A
ROA(3y)-36.98%
ROA(5y)N/A
ROE(3y)-55.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBLL Yearly ROA, ROE, ROICCBLL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

CBLL has a better Gross Margin (86.72%) than 97.35% of its industry peers.
CBLL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBLL Yearly Profit, Operating, Gross MarginsCBLL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

CBLL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBLL has more shares outstanding
Compared to 1 year ago, CBLL has an improved debt to assets ratio.
CBLL Yearly Shares OutstandingCBLL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
CBLL Yearly Total Debt VS Total AssetsCBLL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

CBLL has an Altman-Z score of 14.02. This indicates that CBLL is financially healthy and has little risk of bankruptcy at the moment.
CBLL's Altman-Z score of 14.02 is amongst the best of the industry. CBLL outperforms 93.12% of its industry peers.
CBLL has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
CBLL's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. CBLL outperforms 60.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 14.02
ROIC/WACCN/A
WACC8.98%
CBLL Yearly LT Debt VS Equity VS FCFCBLL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

CBLL has a Current Ratio of 16.73. This indicates that CBLL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 16.73, CBLL belongs to the top of the industry, outperforming 97.88% of the companies in the same industry.
A Quick Ratio of 16.19 indicates that CBLL has no problem at all paying its short term obligations.
CBLL has a better Quick ratio (16.19) than 98.41% of its industry peers.
Industry RankSector Rank
Current Ratio 16.73
Quick Ratio 16.19
CBLL Yearly Current Assets VS Current LiabilitesCBLL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CBLL have decreased strongly by -30.29% in the last year.
The Revenue has grown by 44.71% in the past year. This is a very strong growth!
EPS 1Y (TTM)-30.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)44.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CBLL will show a very strong growth in Earnings Per Share. The EPS will grow by 24.48% on average per year.
CBLL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.07% yearly.
EPS Next Y46.59%
EPS Next 2Y24.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year30.33%
Revenue Next 2Y29.97%
Revenue Next 3Y31.07%
Revenue Next 5YN/A

3.3 Evolution

CBLL Yearly Revenue VS EstimatesCBLL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 50M 100M
CBLL Yearly EPS VS EstimatesCBLL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CBLL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CBLL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBLL Price Earnings VS Forward Price EarningsCBLL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBLL Per share dataCBLL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

CBLL's earnings are expected to grow with 24.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.48%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CBLL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CERIBELL INC

NASDAQ:CBLL (3/7/2025, 8:10:04 PM)

After market: 22.69 0 (0%)

22.69

+0.47 (+2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)N/A N/A
Inst Owners70.12%
Inst Owner ChangeN/A
Ins Owners9.52%
Ins Owner Change13.02%
Market Cap813.89M
Analysts85.45
Price Target33.92 (49.49%)
Short Float %3%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-226.44%
Min EPS beat(2)-429.55%
Max EPS beat(2)-23.32%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.49%
Min Revenue beat(2)-0.54%
Max Revenue beat(2)3.52%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.56%
EPS NQ rev (1m)-26.87%
EPS NQ rev (3m)-26.87%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)5.6%
Revenue NQ rev (3m)5.6%
Revenue NY rev (1m)2.98%
Revenue NY rev (3m)2.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.44
P/FCF N/A
P/OCF N/A
P/B 4.26
P/tB 4.26
EV/EBITDA N/A
EPS(TTM)-1.13
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)-1.02
FCFYN/A
OCF(TTM)-0.98
OCFYN/A
SpS1.82
BVpS5.33
TBVpS5.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.95%
ROE -21.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.72%
FCFM N/A
ROA(3y)-36.98%
ROA(5y)N/A
ROE(3y)-55.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 140.05%
Cap/Sales 2.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.73
Quick Ratio 16.19
Altman-Z 14.02
F-Score4
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)209.9%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.91%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y46.59%
EPS Next 2Y24.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)44.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year30.33%
Revenue Next 2Y29.97%
Revenue Next 3Y31.07%
Revenue Next 5YN/A
EBIT growth 1Y-32.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-18.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.18%
OCF growth 3YN/A
OCF growth 5YN/A